La Jolla delisted from Nasdaq as merger talks fail
04 March 2010
Christopher Spillane
Please Login to read the full article.
04 March 2010
Christopher Spillane
christopher.spillane@informa.com
La Jolla Pharmaceuticals will no longer trade on Nasdaq after the stock exchange's hearing panel determined that the company was operating as a "public shell".
The panel reached the decision because La Jolla's assets, other than cash, and its operations are nominal.
The firm has been...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Teva to buy Cephalon for $6.8 billion, topping Valeant's unsolicited bid
- US Capitol Capsule: Group proposes efforts to ensure US innovation competitiveness
- US Capitol Capsule: Obama pushes for crowdfunding, while SEC panel cautious
- US Capitol Capsule: Supreme Court takes another stab at refining US patent law
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
